< Back to all Breaking News
ATOS
4/20/2017 08:04am
Atossa Genetics receives positive interim review in Phase 1 endoxifen study 
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.
